{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:17:08Z","timestamp":1753359428121},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T00:00:00Z","timestamp":1267574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00404-010-1408-2","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T10:46:37Z","timestamp":1267526797000},"page":"695-699","source":"Crossref","is-referenced-by-count":7,"title":["May platelet count be a predictor of low-risk persistent gestational trophoblastic disease?"],"prefix":"10.1007","volume":"283","author":[{"given":"Fatma Ferda","family":"Verit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,3]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/1097-0142(19951115)76:10+<2079::AID-CNCR2820761329>3.0.CO;2-O","volume":"76","author":"RS Berkowitz","year":"1995","unstructured":"Berkowitz RS, Goldstein DP (1995) Gestational trophoblastic disease. Cancer 76:2079\u20132085","journal-title":"Cancer"},{"key":"1408_CR2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(90)92641-T","volume":"335","author":"KD Bagshawe","year":"1990","unstructured":"Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335:1074\u20131076","journal-title":"Lancet"},{"key":"1408_CR3","first-page":"591","volume":"41","author":"A Ayhan","year":"1996","unstructured":"Ayhan A, Tuncer ZS, Halilzade H, Kucukali T (1996) Predictors of persistent disease in women with complete hydatidiform mole. J Reprod Med 41:591\u2013594","journal-title":"J Reprod Med"},{"key":"1408_CR4","first-page":"395","volume":"64","author":"LC Bandy","year":"1984","unstructured":"Bandy LC, Clarke-Pearson DL, Hammond CB (1984) Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol 64:395\u2013399","journal-title":"Obstet Gynecol"},{"key":"1408_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0020-7292(95)02608-8","volume":"52","author":"T Mungan","year":"1996","unstructured":"Mungan T, Kuscu E, Dabakoglu T, Senoz S, Ugur M, Cobanoglu O (1996) Hydatidiform mole: clinical analysis of 310 patients. Int J Gynecol Obstet 52:233\u2013236","journal-title":"Int J Gynecol Obstet"},{"key":"1408_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006250-199203000-00016","volume":"79","author":"JM Lage","year":"1992","unstructured":"Lage JM, Mark SD, Roberts DJ, Goldstein DP, Bernstein MR, Berkowitz RS (1992) A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 79:403\u2013410","journal-title":"Obstet Gynecol"},{"key":"1408_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2005.12.031","volume":"128","author":"M Parnas","year":"2006","unstructured":"Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128:163\u2013168","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1408_CR8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0002-9378(88)90360-2","volume":"158","author":"JB Schlaerth","year":"1988","unstructured":"Schlaerth JB, Morrow CP, Montz FJ, d\u2019Abling G (1988) Initial management of hydatidiform mole. Am J Obstet Gynecol 158:1299\u20131306","journal-title":"Am J Obstet Gynecol"},{"key":"1408_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","volume":"11","author":"EI Kohorn","year":"2001","unstructured":"Kohorn EI (2001) The New FIGO 2000 staging and risk factor scoring system for GTD. Int J Gynecol Cancer 11:73\u201377","journal-title":"Int J Gynecol Cancer"},{"key":"1408_CR10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jsgi.2004.03.003","volume":"11","author":"GJ Burton","year":"2004","unstructured":"Burton GJ, Jauniaux E (2004) Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 11:342\u2013352","journal-title":"J Soc Gynecol Investig"},{"key":"1408_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.placenta.2004.01.003","volume":"25","author":"L Poston","year":"2004","unstructured":"Poston L, Raijmakers MT (2004) Trophoblast oxidative stress, antioxidants and pregnancy outcome\u2013a review. Placenta 25:72\u201378","journal-title":"Placenta"},{"key":"1408_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/plac.2001.0716","volume":"22","author":"NJ Sebire","year":"2001","unstructured":"Sebire NJ, Rees H, Paradinas F, Fisher R, Foskett M, Seckl M, Newlands E (2001) Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies. Placenta 22:725\u2013728","journal-title":"Placenta"},{"key":"1408_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/beog.1999.0007","volume":"13","author":"P Moran","year":"1999","unstructured":"Moran P, Davison JM (1999) Clinical management of established pre-eclampsia. Baillieres Best Pract Res Clin Obstet Gynaecol 13:77\u201393","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"1408_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.1976.tb00827.x","volume":"83","author":"BJ Trudinger","year":"1976","unstructured":"Trudinger BJ (1976) Platelets and intrauterine growth retardation in preeclampsia. Br J Obstet Gynaecol 83:284\u2013286","journal-title":"Br J Obstet Gynaecol"},{"key":"1408_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9378(86)90803-3","volume":"155","author":"TM Stubbs","year":"1986","unstructured":"Stubbs TM, Lazarchick J, Van Dorsten JP, Cox J, Loadholt CB (1986) Evidence of accelerated platelet production and consumption in nonthrombocytopenic pre-eclampsia. Am J Obstet Gynecol 155:263\u2013265","journal-title":"Am J Obstet Gynecol"},{"key":"1408_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijgo.2004.12.033","volume":"89","author":"M Fallahian","year":"2005","unstructured":"Fallahian M, Nabaie F (2005) Subclinical thrombocytopenia and preeclampsia. Int J Gynaecol Obstet 89:47\u201348","journal-title":"Int J Gynaecol Obstet"},{"key":"1408_CR17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.2.6050.1481","volume":"2","author":"FH Tsakok","year":"1976","unstructured":"Tsakok FH, Koh S, Ratnam SS (1976) Coagulation and fibrinolysis in intact hydatidiform molar pregnancy. Br Med J 2:1481\u20131484","journal-title":"Br Med J"},{"key":"1408_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(73)90018-X","volume":"3","author":"HA Leusden van","year":"1973","unstructured":"van Leusden HA (1973) HCG in pathologic pregnancy. Eur Obstet Gynecol Reprod Biol 3:137\u2013146","journal-title":"Eur Obstet Gynecol Reprod Biol"},{"key":"1408_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","volume":"77","author":"FIGO Oncology Committee","year":"2002","unstructured":"FIGO Oncology Committee (2002) FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 77:285\u2013287","journal-title":"Int J Gynaecol Obstet"},{"key":"1408_CR20","first-page":"478","volume":"58","author":"JB Schlaerth","year":"1981","unstructured":"Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D\u2019Ablaing GA (1981) Prognostic characteristics of serum human chorionic gonadotrophin titer regression following molar pregnancy. Obstet Gynecol 58:478\u2013482","journal-title":"Obstet Gynecol"},{"key":"1408_CR21","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.1996.14.10.2769","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D (1996) Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 14:2769\u20132773","journal-title":"J Clin Oncol"},{"key":"1408_CR22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0959-8049(98)00059-8","volume":"34","author":"M Bower","year":"1998","unstructured":"Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3\u00a0years. Eur J Cancer 34:1204\u20131207","journal-title":"Eur J Cancer"},{"key":"1408_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/molehr\/gap027","volume":"15","author":"H Fujiwara","year":"2009","unstructured":"Fujiwara H (2009) Do circulating blood cells contribute to maternal tissue remodeling and embryo-maternal cross-talk around the implantation period? Mol Hum Reprod 15:335\u2013343","journal-title":"Mol Hum Reprod"},{"key":"1408_CR24","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1210\/en.2006-1687","volume":"148","author":"K Furukawa","year":"2007","unstructured":"Furukawa K, Fujiwara H, Sato Y, Zeng BX, Fujii H, Yoshioka S, Nishi E, Nishio T (2007) Platelet is a novel regulator for neovascularization and luteinization during human corpus luteum formation. Endocrinology 148:3056\u20133064","journal-title":"Endocrinology"},{"key":"1408_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","volume":"100","author":"P Hundelshausen von","year":"2007","unstructured":"von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100:27\u201340","journal-title":"Circ Res"},{"key":"1408_CR26","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.ATV.0000095974.95122.EC","volume":"23","author":"DD Wagner","year":"2003","unstructured":"Wagner DD, Burger PC (2003) Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23:2131\u20132137","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1408_CR27","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.4049\/jimmunol.176.11.6991","volume":"176","author":"MP Kuligowski","year":"2006","unstructured":"Kuligowski MP, Kitching AR, Hickey MJ (2006) Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling. J Immunol 176:6991\u20136999","journal-title":"J Immunol"},{"key":"1408_CR28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","volume":"11","author":"M Iannacone","year":"2005","unstructured":"Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Chisari FV, Ruggeri ZM, Guidotti LG (2005) Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11:1167\u20131169","journal-title":"Nat Med"},{"key":"1408_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/blood-2007-09-111302","volume":"112","author":"R Sood","year":"2008","unstructured":"Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H (2008) Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood 112:585\u2013591","journal-title":"Blood"},{"key":"1408_CR30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2005-02-0491","volume":"106","author":"Y Sato","year":"2005","unstructured":"Sato Y, Fujiwara H, Zeng BX, Higuchi T, Yoshioka S, Fujii S (2005) Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries. Blood 106:428\u2013435","journal-title":"Blood"},{"key":"1408_CR31","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592\u20131594","journal-title":"Science"},{"key":"1408_CR32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.ogx.0000146948.19308.c5","volume":"59","author":"JK Baxter","year":"2004","unstructured":"Baxter JK, Weinstein L (2004) HELLP syndrome: the state of the art. Obstet Gynecol Surv 59:838\u2013845","journal-title":"Obstet Gynecol Surv"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1408-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1408-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:54:01Z","timestamp":1559066041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1408-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1408-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,3]]}}}